Belatacept for Renal Allograft Recipients: A Compassionate Use Program.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 12 Jun 2015
At a glance
- Drugs Belatacept (Primary)
- Indications Renal transplant rejection
- Focus Expanded access; Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 13 Jul 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 15 Jan 2010 Actual initiation date changed from Jan 2009 to Jan 2010 as reported by ClinicalTrials.gov.
- 10 Jun 2009 Planned end date changed from 1 Jul 2010 to 1 Jan 2010 as reported by ClinicalTrials.gov.